The EmbryoGENE Network will address three basic and very important questions:
1. What defines a competent, healthy embryo at the molecular level?
2. How, and to what extent, do routine assisted reproductive technologies affect normal development?
3. How does the metabolic state of the dam, and availability of nutrients to the embryo in vivo, drive phenotypic plasticity?
These questions will be systematically addressed by member researchers working to develop the underlying platform technology and/or working under one of four specific research themes.